CPT® Code 52250

1. Indications

The procedure of cystourethroscopy with the insertion of a radioactive substance is indicated for various conditions related to the bladder and urethra. The following are the explicitly provided indications for this procedure:

• Bladder Tumors The primary indication for this procedure is the presence of bladder tumors, which may require visualization, biopsy, or treatment.
• Suspicion of Malignancy Cystourethroscopy is performed when there is a suspicion of malignancy in the bladder, necessitating further investigation and potential intervention.
• Need for Biopsy The procedure is indicated when a tissue sample is needed to confirm a diagnosis or to assess the nature of a suspected tumor.

2. Procedure

The procedure of cystourethroscopy with the insertion of a radioactive substance involves several detailed steps, which are as follows:

• Preparation The patient is positioned appropriately, and the urethral orifice is cleansed with an antiseptic solution to minimize the risk of infection.
• Insertion of Cystoscope A rigid or flexible cystoscope is then introduced through the urethra into the bladder. This instrument allows the physician to visualize the internal structures of the bladder.
• Bladder Filling To enhance visualization, the bladder may be filled with sterile saline. This step helps to expand the bladder and provides a clearer view of the bladder wall and any potential abnormalities.
• Inspection and Identification The bladder is thoroughly inspected, and the ureteral orifices are identified and examined to ensure there are no obstructions or abnormalities present.
• Locating Tumors Any bladder tumors are located during the inspection phase, allowing for targeted intervention.
• Biopsy (if necessary) If a biopsy is indicated, biopsy forceps are used to obtain tissue samples from the identified tumors for further pathological examination.
• Tumor Destruction If treatment is required, electrocautery, laser, or other techniques may be employed to destroy the tumor tissue. An electrocautery device is advanced through the urethroscope to the tumor site, activated, and used to ablate the tumor.
• Radioactive Substance Insertion Following tumor destruction, a radioactive substance is loaded into a delivery device and implanted into the bladder at the site of the malignancy. This step is crucial for providing targeted internal radiation therapy.
• Completion of Procedure After the radioactive implant is placed, all surgical tools, including the cystoscope, are carefully removed from the bladder.
• Post-Procedure Monitoring The radioactive implant may be left in the bladder for several days to ensure effective treatment. Once the internal radiation therapy is completed, the implant is removed using the cystoscope.

3. Post-Procedure

After the cystourethroscopy with the insertion of a radioactive substance, patients may require monitoring for any immediate complications or side effects associated with the procedure. It is expected that the radioactive implant will remain in the bladder for a specified duration, during which the patient may be advised on precautions to minimize exposure to others. Once the treatment is complete, the implant will be removed using the cystoscope. Patients may experience some discomfort or urinary symptoms post-procedure, which should be monitored and managed accordingly. Follow-up appointments may be necessary to assess the effectiveness of the treatment and to discuss any further interventions if required.